Mario Tama/Getty Images News Overview Recently, I've been analyzing different dividend ETFs to determine how they consider a company qualified for a spot in their holdings. Typically, the things that these funds filter for are dividend growth consistency, the CAGR (compound annual growth rate) of the dividend, free cash flow & EPS growth, and a historically positive total return. Reviewing the popular Schwab U.S. Dividend Equity ETF (SCHD), I noticed that Amgen (NASDAQ:AMGN) made the top ten holdings list. ...

The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market.According to a Goldman Sachs analysis, earlier last year, the global industry for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, the sector could expand by more than 16 times to $100 billion.One of the main reasons why top weight-loss stocks have been performing well is the intersection between the underlying solutions and therapeutics addressing issues suc ...

SPROUT 52-Week Data Demonstrate Durable Response and Consistent Safety Profile of Oral Otezla in Children with Moderate to Severe Plaque Psoriasis Late-Breaking Phase 3 Study of Otezla in Palmoplantar Pustulosis Achieves Primary and Secondary Endpoints at 16 Weeks THOUSAND OAKS, Calif., March 9, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new, 52-week results from the Phase 3 SPROUT study examining the use of Otezla® (apremilast) in children and adolescents aged 6 to 17 years with moderate to s ...

6 Of Goldman Sachs Top 2024 Stock Picks Also Pay Big Dividends Chris Hondros / Getty Images The Artificial Intelligence rally over the last year, led by the so-called “Magnificent 7,” has been fantastic if you owned those stocks. However, most of the S&P 500 is treading water and will not likely ever catch up to the hype-driven AI stocks soon.With the market trading at all-time highs, investors will likely be lured into a false sense of financial security. The reality is the United States could be set for ...

The board of directors of General Dynamics today declared a regular quarterly dividend of $1.42 per share on the company's common stock, payable May 10, 2024, to shareholders of record on April 12, 2024. This is the 27th consecutive annual dividend increase authorized by the General Dynamics board and represents a 7.6% increase over last year's dividend.10 mREITs With Impressive Yields »Amgen today announced that its Board of Directors declared a $2.25 per share dividend for the second quarter of 2024. The ...

THOUSAND OAKS, Calif., March 6, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the second quarter of 2024. The dividend will be paid on June 7, 2024, to all stockholders of record as of the close of business on May 17, 2024. About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This a ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this world's largest biotech drugmaker have returned -12.5% over the past month versus the Zacks S&P 500 composite's +2.9% change. The Zacks Medical - Biomedical and Genetics industry, to which Amgen belongs, has gained 1% over this period. Now the key question is: Where could the stock be headed in the near term?Wh ...

Amgen Inc. (NASDAQ:AMGN) TD Cowen 44th Annual Health Care Conference March 5, 2024 9:10 AM ET Company Participants Peter Griffith - Chief Financial Officer Paul Burton - Chief Medical Officer Conference Call Participants Yaron Werber - TD Cowen Yaron Werber All right. Well, welcome once again to the 44th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the Biotech team, and it's a great pleasure to moderate the fireside chat next with Amgen, first fireside chat for the day, so have very high ex ...

Amgen (AMGN) ended the recent trading session at $279.35, demonstrating a -0.35% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss of 0.12%. Elsewhere, the Dow saw a downswing of 0.25%, while the tech-heavy Nasdaq depreciated by 0.41%.Prior to today's trading, shares of the world's largest biotech drugmaker had lost 13.26% over the past month. This has lagged the Medical sector's gain of 3.58% and the S&P 500's gain of 4.83% in that time.The upcoming ...

Much like Big Tech companies ride the AI hype, pharma stocks are counting on valuation boosts from big drug hits and FDA approvals. This anticipation, however, brings to light the importance of discerning which pharma stocks to sell, as not all will sustain their high-growth promises, potentially generating double-digit profits in the short term.This perspective often invites speculation that leads to overvaluation. Over the last three months, the SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) is up nearly 22% ...